PureTech Health plc SEC filings PTCHF
PureTech Health plc has 134 filings in SEC EDGAR's recent list, going back to Sep 22, 2020. Its latest annual report, Form 20-F, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on May 1, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 15F-12B | Filing | May 21, 2026 | — |
| 25 | Filing | May 11, 2026 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2024 | — |
| CORRESP | Letter to the SEC | Oct 11, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2024 | — |
| SC TO-I/A | Filing | Jun 24, 2024 | — |
| SC TO-I/A | Filing | Jun 6, 2024 | — |
| CORRESP | Letter to the SEC | Jun 4, 2024 | — |
| SC TO-I/A | Filing | Jun 4, 2024 | — |
| UPLOAD | Letter from the SEC | May 30, 2024 | — |
| SC TO-I | Filing | May 20, 2024 | — |
| SC TO-C | Filing | Mar 19, 2024 | — |
| CERT | Filing | Nov 13, 2020 | — |
| EFFECT | Filing | Nov 12, 2020 | — |
| SEC STAFF ACTION | Filing | Nov 12, 2020 | — |
| SEC STAFF LETTER | Filing | Nov 12, 2020 | — |
| SEC STAFF LETTER | Filing | Nov 12, 2020 | — |
| 20FR12B/A | Filing | Nov 9, 2020 | — |
| 20FR12B | Filing | Oct 27, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 7, 2020 | — |
| DRS | Filing | Sep 22, 2020 | — |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PTCHF (OTC), PRTCY (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Boston, MA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1782999
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.